JP2007197423A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007197423A5 JP2007197423A5 JP2006342021A JP2006342021A JP2007197423A5 JP 2007197423 A5 JP2007197423 A5 JP 2007197423A5 JP 2006342021 A JP2006342021 A JP 2006342021A JP 2006342021 A JP2006342021 A JP 2006342021A JP 2007197423 A5 JP2007197423 A5 JP 2007197423A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- anticholinergic agent
- extract
- belladonna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 claims 6
- 239000000812 cholinergic antagonist Substances 0.000 claims 6
- KINWYTAUPKOPCQ-YFKPBYRVSA-N Fudosteine Chemical compound OC(=O)[C@@H](N)CSCCCO KINWYTAUPKOPCQ-YFKPBYRVSA-N 0.000 claims 3
- 229950006783 fudosteine Drugs 0.000 claims 3
- CDQGZJGHIVUWQA-UHFFFAOYSA-N 4-[2-(4-hydroxy-3,5-dimethylphenyl)butan-2-yl]-2,6-dimethylphenol Chemical compound C=1C(C)=C(O)C(C)=CC=1C(C)(CC)C1=CC(C)=C(O)C(C)=C1 CDQGZJGHIVUWQA-UHFFFAOYSA-N 0.000 claims 2
- 241001106067 Atropa Species 0.000 claims 2
- 206010011224 Cough Diseases 0.000 claims 2
- 206010036790 Productive cough Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 229940108858 belladonna total alkaloid Drugs 0.000 claims 2
- 206010006451 bronchitis Diseases 0.000 claims 2
- 229940124579 cold medicine Drugs 0.000 claims 2
- 229940000425 combination drug Drugs 0.000 claims 2
- 210000002175 goblet cell Anatomy 0.000 claims 2
- 206010020718 hyperplasia Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 claims 1
- 229930003347 Atropine Natural products 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 claims 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 claims 1
- JTPUMZTWMWIVPA-UHFFFAOYSA-O Isopropamide Chemical compound C=1C=CC=CC=1C(C(N)=O)(CC[N+](C)(C(C)C)C(C)C)C1=CC=CC=C1 JTPUMZTWMWIVPA-UHFFFAOYSA-O 0.000 claims 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 claims 1
- VVWYOYDLCMFIEM-UHFFFAOYSA-N Propantheline Chemical compound C1=CC=C2C(C(=O)OCC[N+](C)(C(C)C)C(C)C)C3=CC=CC=C3OC2=C1 VVWYOYDLCMFIEM-UHFFFAOYSA-N 0.000 claims 1
- 206010057190 Respiratory tract infections Diseases 0.000 claims 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 claims 1
- 229960000396 atropine Drugs 0.000 claims 1
- 208000007451 chronic bronchitis Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 229960001737 isopropamide Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229960000697 propantheline Drugs 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 claims 1
- 229960002646 scopolamine Drugs 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006342021A JP5091474B2 (ja) | 2005-12-27 | 2006-12-20 | フドステインと抗コリン薬を含有する医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005375885 | 2005-12-27 | ||
| JP2005375885 | 2005-12-27 | ||
| JP2006342021A JP5091474B2 (ja) | 2005-12-27 | 2006-12-20 | フドステインと抗コリン薬を含有する医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007197423A JP2007197423A (ja) | 2007-08-09 |
| JP2007197423A5 true JP2007197423A5 (enExample) | 2010-01-07 |
| JP5091474B2 JP5091474B2 (ja) | 2012-12-05 |
Family
ID=38452376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006342021A Expired - Fee Related JP5091474B2 (ja) | 2005-12-27 | 2006-12-20 | フドステインと抗コリン薬を含有する医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5091474B2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010111667A (ja) * | 2008-10-10 | 2010-05-20 | Daiichi Sankyo Healthcare Co Ltd | フェキソフェナジン又はエバスチンを含有する鎮咳及び／又は去痰のための医薬組成物 |
| CN102060958B (zh) * | 2010-11-11 | 2013-01-02 | 天津工业大学 | 一种福多司坦分子印迹聚合物的制备方法 |
| CN104547815A (zh) * | 2015-02-02 | 2015-04-29 | 徐蕊 | 一种治疗慢性支气管炎的中药组合物及制备方法 |
| CN104721573A (zh) * | 2015-04-19 | 2015-06-24 | 臧海阳 | 一种治疗痰湿型慢性支气管炎的中药组合物 |
| CN105267814A (zh) * | 2015-11-26 | 2016-01-27 | 重庆壹心堂贸易有限公司 | 用于治疗尘肺病的中药 |
| CN105362858A (zh) * | 2015-11-27 | 2016-03-02 | 韩立云 | 一种治疗慢性支气管炎的药物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001233765A (ja) * | 2000-02-24 | 2001-08-28 | Ss Pharmaceut Co Ltd | 感冒薬 |
| EP1391200A4 (en) * | 2001-05-25 | 2004-06-16 | Ssp Co Ltd | DRUG |
| US20040147606A1 (en) * | 2001-05-25 | 2004-07-29 | Yoichi Onuki | Medicinal compositions |
-
2006
- 2006-12-20 JP JP2006342021A patent/JP5091474B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008110970A5 (enExample) | ||
| Moulton et al. | Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD | |
| JP2007314517A5 (enExample) | ||
| JP5208473B2 (ja) | アゼラスチンと抗コリン薬を含有する医薬組成物 | |
| JP2009143964A5 (enExample) | ||
| MXPA03010731A (es) | Combinacion de agonista del receptor a2a de adenosina y tiotropio o sus derivados para tratar enfermedades obstructivas de vias aereas. | |
| JP2014506321A5 (enExample) | ||
| UA94909C2 (ru) | Фармацевтическая композиция нейроактивного стероида и ее применение | |
| IL198314A (en) | History of Quinuclidine of (hetero) Acrylic Cyclohepethecarboxylic Acid, Process of Preparation, Medicinal Preparations Containing Them and Use of Drug Preparation for Treatment | |
| UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
| JP2008528761A5 (enExample) | ||
| TW201010704A (en) | Inhibitor of analgesic tolerance | |
| TW200946142A (en) | Tablet | |
| HRP20100373T4 (hr) | Upotreba kombinacije morfina s najmanje jednim opijatnim antagonistom u liječenju ovisnosti o opijatima i u sprječavanju neoralne zloupotrebe opijata kod ovisnika opijatima | |
| JP2007197423A5 (enExample) | ||
| JP2009518415A5 (enExample) | ||
| WO2008025033A3 (en) | Use of il-27 antagonists for the manufacture of a medicament for the treatment of aplastic anemia | |
| NZ547276A (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
| JP5091474B2 (ja) | フドステインと抗コリン薬を含有する医薬組成物 | |
| US20230390281A1 (en) | Opioid for use to reduce and/or drug addiction | |
| JP2011500650A5 (enExample) | ||
| JP2012500248A (ja) | 不安障害の治療 | |
| Maqsood et al. | The role of revefenacin in chronic obstructive pulmonary disease | |
| US20110313153A1 (en) | 5-ht4 inhibitors for treating airway diseases, in particular asthma | |
| WO2007046113A3 (en) | Novel pharmaceutical composition comprising alkaloid and process thereof |